NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
9.06
+0.44 (5.10%)
Aug 22, 2025, 12:30 PM - Market open
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $299.72 million as of August 22, 2025. Its market cap has increased by 44.70% in one year.
Market Cap
299.72M
Enterprise Value
294.54M
1-Year Change
44.70%
Ranking
Category
Stock Price
$9.06
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $299.72M, a decrease of -23.79%. That is a compound annual growth rate of -6.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 285.16M | -14.62% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 637.28B |
| Johnson & Johnson | 427.82B |
| AbbVie | 364.58B |
| UnitedHealth Group | 273.15B |
| AstraZeneca | 246.07B |
| Novo Nordisk | 241.43B |
| Novartis AG | 240.40B |
| Abbott Laboratories | 228.87B |